Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

CP Invest Fond Farmacie a Biotechnologie

+ Add to Watchlist

FFBCPIN:CP

1.83 CZK

As of 00:00:00 ET on 03/27/2015.

Snapshot for CP Invest Fond Farmacie a Biotechnologie (FFBCPIN)

Year To Date: +8.86% 3-Month: +9.40% 3-Year: +24.33% 52-Week Range: 1.39 - 1.88
1-Month: +1.76% 1-Year: +26.36% 5-Year: +16.05% Beta vs PX: 0.55

Mutual Fund Chart for FFBCPIN

No chart data available.
  • FFBCPIN:CP 1.83
  • 1M
  • 1Y
Interactive FFBCPIN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FFBCPIN

CP Invest Fond Farmacie a Biotechnologie is an open-end fund incorporated in Czech Republic. The Funds objective is long-term capital growth. The fund invests primarily in equity securities issued by larger pharmaceutical and biotechnology companies located in the United States and Europe.

Inception Date: 01-09-2002 Telephone: -
Managers: -
Web Site: -

Fundamentals for FFBCPIN

NAV (on 2015-03-27) 1.83
Assets (M) (on 2015-03-30) 921.26
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for FFBCPIN

No dividends reported

Fees & Expenses for FFBCPIN

Front Load -
Back Load -
Current Mgmt Fee -
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FFBCPIN

Filing Date: 02/28/2015
Name Position Value % of Total
Pfizer Inc 48,838 41,158,459 4.710%
Amgen Inc 9,567 37,051,352 4.240%
Gilead Sciences Inc 14,437 36,701,811 4.200%
Sanofi 12,505 30,147,916 3.450%
Actavis plc 4,189 29,973,145 3.430%
Biogen Inc 2,650 26,652,505 3.050%
Celgene Corp 8,843 26,390,350 3.020%
Johnson & Johnson 10,102 25,429,112 2.910%
Abbott Laboratories 20,884 24,293,103 2.780%
Bayer AG 6,521 23,594,021 2.700%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil